Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Stargardt Macular Degeneration, and Cone Rod Dystrophy Amelogenesis Imperfecta.

Douglas Lazzaro is an Ophthalmologist in New York, New York. Dr. Lazzaro is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Glaucoma, Retinopathy of Prematurity, Interstitial Keratitis, Optic Nerve Atrophy, and Cataract Removal.

Robert Feig is an Ophthalmologist in Brooklyn, New York. Dr. Feig is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Interstitial Keratitis, Kallikrein Hypertension, and Cataract. Dr. Feig is currently accepting new patients in some locations.

David Berman is an Ophthalmologist in Brooklyn, New York. Dr. Berman is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Retinal Vein Occlusion, Retinal Artery Occlusion, Diabetic Retinopathy, and Retinal Detachment.

Joseph Tseng is an Ophthalmologist in New York, New York. Dr. Tseng is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Vitrectomy.

Rubin Brecher is an Ophthalmologist in Brooklyn, New York. Dr. Brecher is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Glaucoma, Optic Atrophy Type 1, and Optic Nerve Atrophy.

Yasha Modi is an Ophthalmologist in New York, New York. Dr. Modi is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Retinal Vein Occlusion, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Gennady Landa is an Ophthalmologist in New York, New York. Dr. Landa is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Landa is currently accepting new patients.

Alexander Pinhas is an Ophthalmologist in New York, New York. Dr. Pinhas is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Retinal Vein Occlusion, Retinal Detachment, and Endophthalmitis. Dr. Pinhas is currently accepting new patients.

Steven Agemy is an Ophthalmologist in New York, New York. Dr. Agemy is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinal Detachment. Dr. Agemy is currently accepting new patients.

Nazanin Barzideh is an Ophthalmologist in New York, New York. Dr. Barzideh is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. Her top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Artery Occlusion.

Sandeep Bhat is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Bhat is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Rabson-Mendenhall Syndrome, and Type 2 Diabetes (T2D).

Meenakashi Gupta is an Ophthalmologist in New York, New York. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. Her top areas of expertise are Diabetic Retinopathy, Endophthalmitis, Late-Onset Retinal Degeneration, Trabeculectomy, and Vitrectomy. Dr. Gupta is currently accepting new patients.

Louis Angioletti is an Ophthalmologist in New York, New York. Dr. Angioletti is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinal Vein Occlusion.

Erik Kruger is an Ophthalmologist in New York, New York. Dr. Kruger is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Choroid Plexus Carcinoma. Dr. Kruger is currently accepting new patients.

John Khadem is an Ophthalmologist in New York, New York. Dr. Khadem is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Retinal Detachment, Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Cristiana Pieroni is an Ophthalmologist in New York, New York. Dr. Pieroni is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. Her top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Late-Onset Retinal Degeneration, and Central Serous Chorioretinopathy.

Jeffrey Rubin is an Ophthalmologist in Brooklyn, New York. Dr. Rubin is rated as a Distinguished provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Experienced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

David Rubaltelli is an Ophthalmologist in Brooklyn, New York. Dr. Rubaltelli is rated as an Advanced provider by MediFind in the treatment of Diabetic Retinopathy. His top areas of expertise are Diabetic Retinopathy, Kallikrein Hypertension, Congenital Toxoplasmosis, and Late-Onset Retinal Degeneration.